S&P ASX All Technology

US Dollar vs AUD

Register to chat with like-minded investors on our interactive forums.

Get Started

AVTE Aerovate Therapeutics Inc

21.60

-0.90 (-4.00%)

After Hours

Last Updated: 07:30:00

Delayed by 15 minutes

Aerovate climbs over 20% after announcing trial initiation

To read the full story on Seeking Alpha, click here.

Aerovate Therapeutics (NASDAQ:AVTE)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Aerovate Therapeutics Charts.

Aerovate Therapeutics (NASDAQ:AVTE)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Aerovate Therapeutics Charts.

Aerovate Therapeutics Inc News

Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference
Thursday 28 March 2024 (3 weeks ago) • GlobeNewswire Inc.

Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
Tuesday 26 March 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 8 March 2024 (1 month ago) • Edgar (US Regulatory)

Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
Thursday 7 March 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 21 February 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Saturday 10 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

More Aerovate Therapeutics Inc News Articles

JP Morgan Chase

Gold vs US Dollar

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions